Podcast Summary
After getting completely hacked and losing our entire social media presence, we're pivoting HARD - and it might be exactly what we needed. In this raw, unfiltered episode, Dr. Matthew Weiner and Zoe break down: - WHY we stopped prescribing the "new" Wegovy pill (spoiler: it's 5 years old and we have data you need to hear) - The GLP-1 medication coming in 2026 that could change everything - Retatrutide clinical trial results revealed - How to get REAL Eli Lilly medication for $150/month (not c...
In this episode of The Pound of Cure Podcast, Dr. Matthew Weiner and Zoë Schroeder discuss the practical weight loss lessons behind Episode 78: Why We STOPPED Prescribing This $200 Weight Loss Pill (Wegovy Oral vs. Injectable Truth). The conversation connects medical weight loss, bariatric surgery, GLP-1 medications, nutrition, and long-term metabolic health.
Patients who are comparing treatment options can use this episode to better understand how evidence-based obesity care works in real life, including the role of food quality, medication support, surgery, mindset, and ongoing follow-up.
Talk with our team
Have questions about this episode?
Send our Tucson weight loss team a note about bariatric surgery, GLP-1 medications, nutrition, or your next step with Pound of Cure.
More from this episode
This episode includes a full transcript. The detailed episode guide should be regenerated from that transcript when AI summary generation is available.
Weight loss topics covered in this episode
This conversation is part of the Pound of Cure approach to evidence-based weight loss education, including bariatric surgery, GLP-1 medications, nutrition counseling, metabolic health, and long-term patient support.
For more context, explore our guides to GLP-1 medications, bariatric surgery in Tucson, and the Metabolic Reset Diet.